Lockheed Martin Investment Management’s Biogen BIIB Stock Holding History

Lockheed Martin Investment Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,000	Closed	-$821K	–	86
2018 Q1	$821K	Hold	3,000	–	–	0.03%	100
2017 Q4	$956K	Buy	3,000 +1,000	+50%	+$321K	0.04%	100
2017 Q3	$626K	Buy	+2,000	New	+$592K	0.03%	121
2015 Q4	–	Sell	-7,600	Closed	-$2.22M	–	89
2015 Q3	$2.22M	Buy	+7,600	New	+$2.51M	0.25%	45
2015 Q1	–	Sell	-3,600	Closed	-$1.22M	–	127
2014 Q4	$1.22M	Sell	3,600 -8,200	-69%	-$2.65M	0.05%	89
2014 Q3	$3.9M	Hold	11,800	–	–	0.18%	49
2014 Q2	$3.72M	Sell	11,800 -8,000	-40%	-$2.41M	0.17%	53
2014 Q1	$6.06M	Sell	19,800 -9,700	-33%	-$3.08M	0.31%	52
2013 Q4	$8.25M	Buy	+29,500	New	+$7.63M	0.46%	45

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Lockheed Martin Investment Management's BIIB Position: Q2 2018 in Review

Lockheed Martin Investment Management sold out of Biogen (BIIB) in Q2 2018, closing a stake of 3,000 shares — an estimated $821K sold.

Lockheed Martin Investment Management first reported a position in BIIB in Q4 2013 and held it in 9 quarters. The position peaked at $8.25M in Q4 2013. 1,097 funds tracked by Wall St. Rank hold BIIB as of Q2 2018.

Lockheed Martin Investment Management reported no remaining Biogen position as of Q2 2018 after selling out during the quarter.
Lockheed Martin Investment Management sold 3,000 Biogen shares in Q2 2018, an estimated $821K.
Lockheed Martin Investment Management first reported a position in Biogen in Q4 2013 and held it in 9 quarters.
Lockheed Martin Investment Management's Biogen position peaked at $8.25M in Q4 2013.
1,097 funds tracked by Wall St. Rank held Biogen as of Q2 2018.

Based on Lockheed Martin Investment Management's 13F filing for Q2 2018, filed 14 Aug 2018.